View in EDS HTML Full Text PDF Full Text

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.

Saved in:
Bibliographic Details
Title: Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
Authors: Brown D; Community Clinical Research, Inc, Austin, TX., Nakagome K; Department of Forensic Psychiatry, National Center of Neurology and Psychiatry, Kodaira, Japan., Cordes J; Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany., Brenner R; Neurobehavioral Research, Inc, New York, NY., Gründer G; Department of Molecular Neuroimaging, Central Institute of Mental Health, Clinical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Keefe RSE; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC., Riesenberg R; Atlanta Center for Medical Research, Atlanta, GA., Walling DP; CNS Network, Inc, Garden Grove, CA., Daniels K; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT., Wang L; Boehringer Ingelheim Taiwan Limited, Taipei, Taiwan., McGinniss J; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT., Sand M; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT.
Source: Schizophrenia bulletin [Schizophr Bull] 2019 Mar 07; Vol. 45 (2), pp. 350-359.
Publication Type: Adaptive Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0236760 Publication Model: Print Cited Medium: Internet ISSN: 1745-1701 (Electronic) Linking ISSN: 05867614 NLM ISO Abbreviation: Schizophr Bull Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29718385
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brown+D%22">Brown D</searchLink>; Community Clinical Research, Inc, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Nakagome+K%22">Nakagome K</searchLink>; Department of Forensic Psychiatry, National Center of Neurology and Psychiatry, Kodaira, Japan.<br /><searchLink fieldCode="AU" term="%22Cordes+J%22">Cordes J</searchLink>; Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Brenner+R%22">Brenner R</searchLink>; Neurobehavioral Research, Inc, New York, NY.<br /><searchLink fieldCode="AU" term="%22Gründer+G%22">Gründer G</searchLink>; Department of Molecular Neuroimaging, Central Institute of Mental Health, Clinical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Keefe+RSE%22">Keefe RSE</searchLink>; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Riesenberg+R%22">Riesenberg R</searchLink>; Atlanta Center for Medical Research, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; CNS Network, Inc, Garden Grove, CA.<br /><searchLink fieldCode="AU" term="%22Daniels+K%22">Daniels K</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Boehringer Ingelheim Taiwan Limited, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22McGinniss+J%22">McGinniss J</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT.<br /><searchLink fieldCode="AU" term="%22Sand+M%22">Sand M</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220236760%22">Schizophrenia bulletin</searchLink> [Schizophr Bull] 2019 Mar 07; Vol. 45 (2), pp. 350-359.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Adaptive Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0236760 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-1701 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2205867614%22">05867614 </searchLink><i>NLM ISO Abbreviation: </i>Schizophr Bull <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29718385
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/schbul/sby049
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 350
    Titles:
      – TitleFull: Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brown D
      – PersonEntity:
          Name:
            NameFull: Nakagome K
      – PersonEntity:
          Name:
            NameFull: Cordes J
      – PersonEntity:
          Name:
            NameFull: Brenner R
      – PersonEntity:
          Name:
            NameFull: Gründer G
      – PersonEntity:
          Name:
            NameFull: Keefe RSE
      – PersonEntity:
          Name:
            NameFull: Riesenberg R
      – PersonEntity:
          Name:
            NameFull: Walling DP
      – PersonEntity:
          Name:
            NameFull: Daniels K
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: McGinniss J
      – PersonEntity:
          Name:
            NameFull: Sand M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 03
              Text: 2019 Mar 07
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1745-1701
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Schizophrenia bulletin
              Type: main
ResultId 1